Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

AstraZeneca claims novel 2-pyrazinylbenzimidazole derivatives for cancer treatment

April 3, 2009

Substituted CC-1065 analogues claimed by Syntarga

April 3, 2009

Merck KGaA describes new tyrosine kinase inhibitors for cancer treatment

April 3, 2009

Novel cancer therapeutic compounds claimed by the State University of New Jersey

April 3, 2009

GSK submits lapatinib for first-line breast cancer treatment in U.S. and E.U.

April 2, 2009

PF-04217903 pharmacokinetics investigated in phase I study

April 2, 2009

Phase I data on AVE-8062 in advanced solid tumor patients presented

April 2, 2009

Halozyme commences PEGPH-20 dosing in patients with refractory solid tumors

April 2, 2009

Roche claims pyridoneamide derivatives as focal adhesion kinase inhibitors

April 2, 2009

AstraZeneca discloses new series of Janus kinase inhibitors for cancer treatment

April 2, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026